The macrophages in meningioma had one drug-target kinase that was significantly increased in expression compared to VS (FLT3), whereas VS had two drug-target kinases, FGFR2 and FGFR3 (Fig. 5B). The gene discussed is FGFR3; the disease is meningioma.